Advanced search
Publication Cover
The World Journal of Biological Psychiatry Volume 11, 2010 - Issue 2
Submit an article Journal homepage
1,539
Views
289
CrossRef citations to date
0
Altmetric
GUIDELINES

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression

Heinz Grunze Newcastle University, Institute of Neuroscience, Newcastle upon Tyne, UK; Department of Psychiatry, Ludwig-Maximilians-University, Munich, GermanyCorrespondence[email protected]
,
Eduard Vieta Bipolar Disorders Programme, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain
,
Guy M. Goodwin Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK
,
Charles Bowden Department of Psychiatry, University of Texas Health Science Center, San Antonio, TX, USA
,
Rasmus W. Licht Mood Disorders Research Unit, Aarhus University Hospital, Risskov, Denmark
,
Hans-Jürgen Möller Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany
,
Siegfried Kasper Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
& WFSBP Task Force On Treatment Guidelines For Bipolar Disorders show all
Pages 81-109 | Received 14 Dec 2009, Accepted 14 Dec 2009, Published online: 12 Feb 2010

Citations (289)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (36)

Omar H Elsayed, Mete Ercis, Mehak Pahwa & Balwinder Singh. (2022) Treatment-Resistant Bipolar Depression: Therapeutic Trends, Challenges and Future Directions. Neuropsychiatric Disease and Treatment 18, pages 2927-2943.
Read now
Nefize Yalin & Allan H Young. (2020) Pharmacological Treatment of Bipolar Depression: What are the Current and Emerging Options?. Neuropsychiatric Disease and Treatment 16, pages 1459-1472.
Read now
Elie Cheniaux & Antonio E. Nardi. (2019) Evaluating the efficacy and safety of antidepressants in patients with bipolar disorder. Expert Opinion on Drug Safety 18:10, pages 893-913.
Read now
Raoul Belzeaux, Catherine Sanguinetti, Andrea Murru, Norma Verdolini, Isabella Pacchiarotti, Diego Hidalgo-Mazzei, Lola Cohen, Gerard Anmella, Margherita Barbuti, Eduard Vieta, Pierre-Michel Llorca & Ludovic Samalin. (2019) Pharmacotherapy for the peripartum management of bipolar disorder. Expert Opinion on Pharmacotherapy 20:14, pages 1731-1741.
Read now
Siegfried Kasper. (2019) A thank-you note from the Chief-Editor. The World Journal of Biological Psychiatry 20:4, pages 254-257.
Read now
Heinz Grunze, Eduard Vieta, Guy M. Goodwin, Charles Bowden, Rasmus W. Licht, Jean-Michel Azorin, Lakshmi Yatham, Sergey Mosolov, Hans-Jürgen Möller & Siegfried Kasper. (2018) The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder. The World Journal of Biological Psychiatry 19:1, pages 2-58.
Read now
Petru Ifteni, Andreea Teodorescu, Marius Alexandru Moga, Alina Mihaela Pascu & Roxana Steliana Miclaus. (2017) Switching bipolar disorder patients treated with clozapine to another antipsychotic medication: a mirror image study. Neuropsychiatric Disease and Treatment 13, pages 201-204.
Read now
Richard D. Weiner & Irving M. Reti. (2017) Key updates in the clinical application of electroconvulsive therapy. International Review of Psychiatry 29:2, pages 54-62.
Read now
Lucio Oldani, A. Carlo Altamura, Mohamed Abdelghani & Allan H. Young. (2016) Brain stimulation treatments in bipolar disorder: A review of the current literature. The World Journal of Biological Psychiatry 17:7, pages 482-494.
Read now
Charles L Bowden & Vivek Singh. (2016) The use of antidepressants in bipolar disorder patients with depression. Expert Opinion on Pharmacotherapy 17:1, pages 17-25.
Read now
Jong-Hyun Jeong, Jeong Goo Lee, Moon-Doo Kim, Inki Sohn, Se-Hoon Shim, Hee Ryung Wang, Young Sup Woo, Duk-In Jon, Jeong Seok Seo, Young-Chul Shin, Kyung Joon Min, Bo-Hyun Yoon & Won-Myong Bahk. (2015) Korean Medication Algorithm for Bipolar Disorder 2014: comparisons with other treatment guidelines. Neuropsychiatric Disease and Treatment 11, pages 1561-1571.
Read now
Bernardo Dell’Osso, Umberto Albert, Anna Rita Atti, Claudia Carmassi, Giuseppe Carrà, Fiammetta Cosci, Valeria Del Vecchio, Marco Di Nicola, Silvia Ferrari, Arianna Goracci, Felice Iasevoli, Mario Luciano, Giovanni Martinotti, Maria Giulia Nanni, Alessandra Nivoli, Federica Pinna, Nicola Poloni, Maurizio Pompili, Gaia Sampogna, Ilaria Tarricone, Sarah Tosato, Umberto Volpe & Andrea Fiorillo. (2015) Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice. Neuropsychiatric Disease and Treatment 11, pages 1885-1909.
Read now
Young Sup Woo, Jung Goo Lee, Jong-Hyun Jeong, Moon-Doo Kim, Inki Sohn, Se-Hoon Shim, Duk-In Jon, Jeong Seok Seo, Young-Chul Shin, Kyung Joon Min, Bo-Hyun Yoon & Won-Myong Bahk. (2015) Korean Medication Algorithm Project for Bipolar Disorder: third revision. Neuropsychiatric Disease and Treatment 11, pages 493-506.
Read now
Eva Maria Pichler, Georg Hattwich, Heinz Grunze & Moritz Muehlbacher. (2015) Safety and tolerability of anticonvulsant medication in bipolar disorder. Expert Opinion on Drug Safety 14:11, pages 1703-1724.
Read now
Michael Bauer, Emanuel Severus, Stephan Köhler, Peter C. Whybrow, Jules Angst & Hans-Jürgen Möller. (2015) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders. Part 2: Maintenance Treatment of Major Depressive Disorder-Update 2015. The World Journal of Biological Psychiatry 16:2, pages 76-95.
Read now
Kiran Kumar Sayyaparaju, Heinz Grunze & Kostas N Fountoulakis. (2014) When to start aripiprazole therapy in patients with bipolar mania. Neuropsychiatric Disease and Treatment 10, pages 459-470.
Read now
Sirijit Suttajit, Manit Srisurapanont, Narong Maneeton & Benchalak Maneeton. (2014) Quetiapine for acute bipolar depression: a systematic review and meta-analysis. Drug Design, Development and Therapy 8, pages 827-838.
Read now
Ludovic Samalin, Aurore Tremey & Pierre-Michel Llorca. (2014) Quetiapine extended release for the treatment of bipolar disorder. Expert Review of Neurotherapeutics 14:9, pages 987-1005.
Read now
Cecilio Álamo, Francisco López-Muñoz & Pilar García-García. (2014) The effectiveness of lurasidone as an adjunct to lithium or divalproex in the treatment of bipolar disorder. Expert Review of Neurotherapeutics 14:6, pages 593-605.
Read now
Ludovic Samalin, Aurore Nourry, Thomas Charpeaud & Pierre-Michel Llorca. (2014) What is the evidence for the use of second-generation antipsychotic long-acting injectables as maintenance treatment in bipolar disorder?. Nordic Journal of Psychiatry 68:4, pages 227-235.
Read now
Anja Tränkner, Christian Sander & Peter Schönknecht. (2013) A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder. Neuropsychiatric Disease and Treatment 9, pages 101-111.
Read now
. (2013) Abstracts. International Journal of Psychiatry in Clinical Practice 17:sup2, pages 1-39.
Read now
Michael Bauer, Andrea Pfennig, Emanuel Severus, Peter C. Whybrow, Jules Angst & Hans-Jürgen Möller. (2013) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders. The World Journal of Biological Psychiatry 14:5, pages 334-385.
Read now
Giovanni Martinotti, Gianna Sepede, Maria Signorelli, Eugenio Aguglia & Massimo Di Giannantonio. (2013) Efficacy and safety of fluoxetine monotherapy in bipolar depression: a systematic review. Expert Opinion on Pharmacotherapy 14:8, pages 1065-1075.
Read now
Heinz Grunze, Eduard Vieta, Guy M. Goodwin, Charles Bowden, Rasmus W. Licht, Hans-Jürgen Möller & Siegfried Kasper. (2013) The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder. The World Journal of Biological Psychiatry 14:3, pages 154-219.
Read now
Terry Ann Glauser, Wendy Cerenzia, Shereta Wiley, Alexandra Howson & Michael Thase. (2013) Identifying Psychiatrists' Practice Patterns When Managing Depression in Patients with Bipolar I Disorder: A Descriptive Study to Inform Education Needs. Postgraduate Medicine 125:1, pages 144-153.
Read now
Nizar El-Khalili. (2012) Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders. Neuropsychiatric Disease and Treatment 8, pages 523-536.
Read now
Peter Niemegeers, Kristof E Maudens, Manuel Morrens, Lisbeth Patteet, Leen Joos, Hugo Neels & Bernard GC Sabbe. (2012) Pharmacokinetic evaluation of armodafinil for the treatment of bipolar depression. Expert Opinion on Drug Metabolism & Toxicology 8:9, pages 1189-1197.
Read now
Philip G Janicak & Jeffrey T Rado. (2012) Quetiapine for the treatment of acute bipolar mania, mixed episodes and maintenance therapy. Expert Opinion on Pharmacotherapy 13:11, pages 1645-1652.
Read now
Michael E. Thase, Charles L. Bowden, Michael Nashat, James M. Eudicone, Ronald Marcus, Robert D. Mcquade & Berit X. Carlson. (2012) Aripiprazole in bipolar depression: a pooled, post-hoc analysis by severity of core depressive symptoms. International Journal of Psychiatry in Clinical Practice 16:2, pages 121-131.
Read now
Charlotte L. Allan & Klaus P. Ebmeier. (2011) The Use of ECT and MST in treating depression. International Review of Psychiatry 23:5, pages 400-412.
Read now
Fernando Cañas, Christoph U Correll, Andrea Fagiolini, Ilkka Larmo, Pedro Levy, Georgios Papageorgiou, Alessandro Rossi, Marhias Zink & José Manuel Montes. (2011) Practical guidance for prescribing ziprasidone in acute manic or mixed episodes of bipolar I disorder. Expert Opinion on Pharmacotherapy 12:14, pages 2245-2263.
Read now
Philip G Janicak & Jeffrey T Rado. (2011) Quetiapine monotherapy for bipolar depression. Expert Opinion on Pharmacotherapy 12:10, pages 1643-1651.
Read now
Emilio Sacchetti, Alessandro Galluzzo & Paolo Valsecchi. (2011) Oral ziprasidone in the treatment of patients with bipolar disorders: a critical review. Expert Review of Clinical Pharmacology 4:2, pages 163-179.
Read now
A Carlo Altamura, Licia Lietti, Cristina Dobrea, Beatrice Benatti, Chiara Arici & Bernardo Dell’Osso. (2011) Mood stabilizers for patients with bipolar disorder: the state of the art. Expert Review of Neurotherapeutics 11:1, pages 85-99.
Read now
Michele Fornaro. (2010) Obsessive-compulsive disorder with bipolar diathesis following isotretinoin therapy remitting upon treatment with olanzapine and fluvoxamine. Neuropsychiatric Disease and Treatment 6, pages 719-722.
Read now

Articles from other publishers (253)

Nemanja LjubicBianca UeberbergHeinz GrunzeHans-Jörg Assion. (2023) Treatment of Bipolar Disorders in Older Adults: A Review. FOCUS 21:4, pages 434-443.
Crossref
Ayşegül Yildiz, Spyridon Siafis, Dimitris Mavridis, Eduard Vieta & Stefan Leucht. (2023) Comparative efficacy and tolerability of pharmacological interventions for acute bipolar depression in adults: a systematic review and network meta-analysis. The Lancet Psychiatry 10:9, pages 693-705.
Crossref
Sang Jin Rhee, Henrik Ohlsson, Jan Sundquist, Kristina Sundquist & Kenneth S. Kendler. (2023) Predictors of diagnostic conversion from major depression to bipolar disorder: a Swedish national longitudinal study. Psychological Medicine, pages 1-12.
Crossref
Jeffrey J. Rakofsky, Michael J. Lucido & Boadie W. Dunlop. (2023) All studies are not created equal: A systematic narrative review of bipolar depression clinical trial inclusion/exclusion rules and baseline severity scores. Journal of Affective Disorders 333, pages 130-139.
Crossref
Chih-Ming Cheng, Wei-Hung Chang, Yi-Ting Lin, Po-See Chen, Yen-Kuang Yang & Ya-Mei Bai. (2023) Taiwan consensus on biological treatment of bipolar disorder during the acute, maintenance, and mixed phases: The 2022 update. Asian Journal of Psychiatry 82, pages 103480.
Crossref
Jong-Hyun Jeong, Won-Myong Bahk, Young Sup Woo, Bo-Hyun Yoon, Jung Goo Lee, Won Kim, InKi Sohn, Sung-Yong Park, Se-Hoon Shim, Jeong Seok Seo, IL Han Choo, Chan-Mo Yang, Myung Hun Jung, Duk-In Jon & Moon-Doo Kim. (2023) Korean Medication Algorithm Project for Bipolar Disorder 2022: Comparisons with Other Treatment Guidelines. Clinical Psychopharmacology and Neuroscience 21:1, pages 32-48.
Crossref
Julian Mutz. (2022) Brain stimulation treatment for bipolar disorder. Bipolar Disorders 25:1, pages 9-24.
Crossref
A. Ratheesh, D. Hett, J. Ramain, E. Wong, L. Berk, P. Conus, M. A. Fristad, T. Goldstein, M. Hillegers, S. Jauhar, L. V. Kessing, D. J. Miklowitz, G. Murray, J. Scott, M. Tohen, L. N. Yatham, A. H. Young, M. Berk & S. Marwaha. (2023) A systematic review of interventions in the early course of bipolar disorder I or II: a report of the International Society for Bipolar Disorders Taskforce on early intervention. International Journal of Bipolar Disorders 11:1.
Crossref
Calogero Crapanzano, Ilaria Casolaro, Chiara Amendola & Stefano Damiani. (2022) Lithium and Valproate in Bipolar Disorder: From International Evidence-based Guidelines to Clinical Predictors. Clinical Psychopharmacology and Neuroscience 20:3, pages 403-414.
Crossref
Jeffrey J. Rakofsky, Michael J. Lucido & Boadie W. Dunlop. (2022) Lithium in the treatment of acute bipolar depression: A systematic review and meta-analysis. Journal of Affective Disorders 308, pages 268-280.
Crossref
Chih-Ken Chen, Lawrence Shih-Hsin Wu, Ming-Chyi Huang, Chian-Jue Kuo & Andrew Tai-Ann Cheng. (2022) Antidepressant Treatment and Manic Switch in Bipolar I Disorder: A Clinical and Molecular Genetic Study. Journal of Personalized Medicine 12:4, pages 615.
Crossref
K.W.F. Scheepstra, J.B. van Doorn, D.S. Scheepens, A. de Haan, N. Schukking, J.B. Zantvoord & A. Lok. (2022) 'Rapid speed of response to ECT in bipolar depression: A chart review. Journal of Psychiatric Research 147, pages 34-38.
Crossref
Fabiano A. Gomes, Raphael O. Cerqueira, Yena Lee, Rodrigo B. Mansur, Flavio Kapczinski, Roger S. McIntyre, Lakshmi N. Yatham, Michael Berk, Roumen Milev & Elisa Brietzke. (2022) What not to use in bipolar disorders: A systematic review of non-recommended treatments in clinical practice guidelines. Journal of Affective Disorders 298, pages 565-576.
Crossref
Guoqing Chen, Honggang Lv, Xiao Zhang, Yan Gao, Xia Liu, Chuanzheng Gu, Ranran Xue, Qiuling Wang, Min Chen, Jinguo Zhai, Weihua Yue & Hao Yu. (2022) Assessment of the relationships between genetic determinants of thyroid functions and bipolar disorder: A mendelian randomization study. Journal of Affective Disorders 298, pages 373-380.
Crossref
Konstantinos N Fountoulakis, Mauricio Tohen & Carlos A. ZarateJR.JR.. (2022) Lithium treatment of Bipolar disorder in adults: A systematic review of randomized trials and meta-analyses. European Neuropsychopharmacology 54, pages 100-115.
Crossref
Cora Schefft, Constantin Volkmann & Stephan Köhler. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 4075 4093 .
Jelena Vrublevska & Lubova Renemane. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 823 853 .
Deepak PatilSeema PattewarSarvesh PalivalGargi PatilSwapnil Sharma. (2021) Fabrication and characterization of nanostructured lipid carrier system for effective delivery of poorly water-soluble drug quetiapine fumarate. Research Journal of Pharmacy and Technology, pages 6235-6244.
Crossref
Klaus Munkholm, Karsten Juhl Jørgensen & Asger Sand Paludan-Müller. (2021) Adverse effects of electroconvulsive therapy. Cochrane Database of Systematic Reviews 2021:12.
Crossref
David M. Taylor, Thomas R. E. Barnes & Allan H. Young. 2021. The Maudsley Prescribing Guidelines in Psychiatry. The Maudsley Prescribing Guidelines in Psychiatry 247 304 .
Jurriaan M. J. L. Brouwer, Erien Olde Hengel, Arne J. Risselada, Eric N. van Roon & Hans Mulder. (2021) Applicability of somatic monitoring instructions in clinical practice guidelines on antipsychotic drug use. BMC Psychiatry 21:1.
Crossref
Ta-Chuan Yeh, Ya-Mei Bai, Ju-Wei Hsu, Kai-Ling Huang, Shih-Jen Tsai, Hsuan-Te Chu, Chih-Sung Liang & Mu-Hong Chen. (2021) Bipolar women's antepartum psychotropic exposure and offspring risk of attention-deficit/hyperactivity disorder and autism spectrum disorder. Journal of Affective Disorders 295, pages 1407-1414.
Crossref
Klaus Munkholm, Karsten Juhl Jørgensen & Asger Sand Paludan-Müller. (2021) Electroconvulsive therapy for preventing relapse and recurrence in bipolar disorder. Cochrane Database of Systematic Reviews 2021:11.
Crossref
Sune Puggaard Vogt Straszek, René E. Nielsen, Zoltan Kovacs & Rasmus W. Licht. (2021) Lithium as a first‐step option for acute phase pharmacotherapy of bipolar depression. Bipolar Disorders 23:7, pages 726-727.
Crossref
Klaus Munkholm, Karsten Juhl Jørgensen & Asger Sand Paludan-Müller. (2021) Electroconvulsive therapy for acute affective episodes in people with bipolar disorder. Cochrane Database of Systematic Reviews 2021:10.
Crossref
Lars Vedel Kessing, Natacha Blauenfeldt Kyster, Pernille Bondo-Kozuch, Ellen Margrethe Christensen, Birgitte Vejstrup, Birte Smidt, Anne-Marie Bangsgaard Jørgensen, Raben Rosenberg, Darius Mardosas, Louise Behrend Rasmussen, Maj Vinberg, Ida Hageman & Maria Faurholt-Jepsen. (2021) Effect of specialised versus generalised outpatient treatment for bipolar disorder: the CAG Bipolar trial - study protocol for a randomised controlled trial. BMJ Open 11:10, pages e048821.
Crossref
Bernardo Dell'Osso, Chiara Arici, Rita Cafaro, Matteo Vismara, Laura Cremaschi, Beatrice Benatti, Monica Macellaro, Caterina Viganò & Terence A. Ketter. (2021) Antidepressants in bipolar disorder: Analysis of correlates overall, and in BD-I and BD-II subsamples. Journal of Affective Disorders 292, pages 352-358.
Crossref
Anna Grunze, Benedikt L. Amann & Heinz Grunze. (2021) Efficacy of Carbamazepine and Its Derivatives in the Treatment of Bipolar Disorder. Medicina 57:5, pages 433.
Crossref
Frank M.C. Besag, Michael J. Vasey, Aditya N. Sharma & Ivan C.H. Lam. (2021) Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: a systematic review. Therapeutic Advances in Psychopharmacology 11, pages 204512532110458.
Crossref
Priya Sunder, Ming-Fang Chia, Kate Filia, Craig Macneil, Melissa Hasty, Christopher Davey, Patrick McGorry, Michael Berk, Sue Cotton & Aswin Ratheesh. (2021) Does guideline-concordant care predict naturalistic outcomes in youth with early stage bipolar I disorder?. Journal of Affective Disorders 278, pages 23-32.
Crossref
Cora Schefft, Constantin Volkmann & Stephan Köhler. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 19 .
Hitoshi Sakurai, Masaki Kato, Norio Yasui-Furukori, Takefumi Suzuki, Hajime Baba, Koichiro Watanabe, Ken Inada, Ikuko Kishida, Yuka Sugawara Kikuchi, Toshiaki Kikuchi, Asuka Katsuki & Hiroyuki Uchida. (2020) Pharmacological management of bipolar disorder: Japanese expert consensus. Bipolar Disorders 22:8, pages 822-830.
Crossref
Yena LeeElisa BrietzkeBing CaoYan ChenOuti LinnarantaRodrigo B MansurPaulina CortesMarkus KöstersAmna MajeedJocelyn K TamuraLeanna M W LuiMaj VinbergJaakko KeinänenSteve KiselySadiq NaveedCorrado BarbuiGary ParkerMayowa OwolabiDaisuke NishiJungGoo LeeManit SrisurapanontHartej GillLan GuoVicent Balanzá-MartínezTimo PartonenWillem A NolenJae-Hon LeeJi Hwan KimNiels H ChavannesTatjana EwaisBeatriz Atienza-CarbonellAnna V SilvenNaonori YasumaArtyom GilAndrey NovikovCameron LaceyAnke VersluisSofia von MalortieLai Fong ChanAhmed WaqasMarianna PurgatoJiska Joëlle AardoomJosefina T Ly-UsonKang SimMaria TuineagRianne M J J van der KleijSanne van LuenenSirijit SuttajitTomas HajekYu Wei LeeRichard J PorterMohammad AlsuwaidanJoshua D RosenblatArun V RavindranRaymond W LamRoger S McIntyre. (2020) Development and implementation of guidelines for the management of depression: a systematic review. Bulletin of the World Health Organization 98:10, pages 683-697H.
Crossref
T. P. Safarova. (2020) Late-Life Depression Treatment: the State of the Art. Psikhiatriya 18:3, pages 95-107.
Crossref
Duk‐In Jon, Young Sup Woo, Jeong‐Seok Seo, Jung Goo Lee, Jong‐Hyun Jeong, Won Kim, Young Chul Shin, Kyung Joon Min, Bo‐Hyun Yoon & Won‐Myong Bahk. (2020) The Korean Medication Algorithm Project for Bipolar Disorder (KMAP‐BP): Changes in preferred treatment strategies and medications over 16 years and five editions. Bipolar Disorders 22:5, pages 461-471.
Crossref
S. S. Potanin & M. A. Morozova. (2020) Is the Prescription of Antidepressants for Bipolar Depression Justified from the Point of View of Evidence-Based Medicine?. Psychiatry 18:2, pages 51-60.
Crossref
Filippo Corponi, Gerard Anmella, Isabella Pacchiarotti, Ludovic Samalin, Norma Verdolini, Dina Popovic, Jean-Michel Azorin, Jules Angst, Charles L. Bowden, Sergey Mosolov, Allan H. Young, Giulio Perugi, Eduard Vieta & Andrea Murru. (2020) Deconstructing major depressive episodes across unipolar and bipolar depression by severity and duration: a cross-diagnostic cluster analysis on a large, international, observational study. Translational Psychiatry 10:1.
Crossref
Shengjun Wang, Zhigang Zhang, Li Yao, Nannan Ding, Lingjie Jiang & Yuchen Wu. (2020) Bright light therapy in the treatment of patients with bipolar disorder: A systematic review and meta-analysis. PLOS ONE 15:5, pages e0232798.
Crossref
Constantin Volkmann, Tom Bschor & Stephan Köhler. (2020) Lithium Treatment Over the Lifespan in Bipolar Disorders. Frontiers in Psychiatry 11.
Crossref
Lister Rossel, Rodrigo Erazo, Rodrigo Nieto, Crisitán Fuentes & Pablo Curivil. (2020) Uso de criterios y guías clínicas en la creación de una unidad de trastornos del ánimo. Revista Médica Clínica Las Condes 31:2, pages 114-121.
Crossref
Maurizio Pompili, Gustavo H. Vazquez, Alberto Forte, Debbi Ann Morrissette & Stephen M. Stahl. (2020) Pharmacologic Treatment of Mixed States. Psychiatric Clinics of North America 43:1, pages 167-186.
Crossref
Hyewon Kim, Yuwon Kim, Ji Hyun Baek, Maurizio Fava, David Mischoulon, Andrew A. Nierenberg, Kwan Woo Choi, Eun Jin Na, Myung-Hee Shin & Hong Jin Jeon. (2020) Predictive factors of diagnostic conversion from major depressive disorder to bipolar disorder in young adults ages 19–34: A nationwide population study in South Korea. Journal of Affective Disorders 265, pages 52-58.
Crossref
Luke A. Jelen & Allan H. Young. (2020) The Treatment of Bipolar Depression: Current Status and Future Perspectives. Current Behavioral Neuroscience Reports 7:1, pages 1-14.
Crossref
Laura Cremaschi, Terence Arthur Ketter, Chiara Arici, Shefali Miller, Farnaz Hooshmand & Bernardo Dell’Osso. (2020) Antipsychotic use in Northern Italian inter-episode bipolar disorder patients. International Clinical Psychopharmacology 35:1, pages 49-58.
Crossref
Thomas D. Meyer & Michael Bauer. 2020. Klinische Psychologie & Psychotherapie. Klinische Psychologie & Psychotherapie 1005 1026 .
Jelena Vrublevska & Lubova Renemane. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 31 .
Maria Uscinska, Andrea Polla Mattiot & Silvio Bellino. 2019. Behavioral Neuroscience. Behavioral Neuroscience.
Maximilian Pilhatsch, Thomas J Stamm, Petra Stahl, Ute Lewitzka, Anne Berghöfer, Cathrin Sauer, Michael Gitlin, Mark A. Frye, Peter C. Whybrow & Michael Bauer. (2019) Treatment of bipolar depression with supraphysiologic doses of levothyroxine: a randomized, placebo-controlled study of comorbid anxiety symptoms. International Journal of Bipolar Disorders 7:1.
Crossref
Shigenobu Kanba, Mitsukuni Murasaki, Tsukasa Koyama, Masahiro Takeuchi, Yuriko Shimizu, Eri Arita, Kentaro Kuroishi, Masahiro Takeuchi & Shinya Kamei. (2019) Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression. BMC Psychiatry 19:1.
Crossref
Heinz Grunze & Schwäbisch Hall. (2019) Fortschritte in der Diagnostik und Behandlung bipolarer Störungen. DNP - Der Neurologe & Psychiater 20:6, pages 74-84.
Crossref
Ming Fang Chia, Sue Cotton, Kate Filia, Mark Phelan, Philippe Conus, Sameer Jauhar, Steven Marwaha, Patrick D McGorry, Christopher Davey, Michael Berk & Aswin Ratheesh. (2019) Early intervention for bipolar disorder – Do current treatment guidelines provide recommendations for the early stages of the disorder?. Journal of Affective Disorders 257, pages 669-677.
Crossref
Jonathan Waite. 2019. The ECT Handbook. The ECT Handbook 121 128 .
R Hamish McAllister-Williams. 2019. The ECT Handbook. The ECT Handbook 32 37 .
Berit Kerner, Annette S Crisanti, Jason L DeShaw, Janika-Marie G Ho, Kimmie Jordan, Ronald L Krall, Matt J Kuntz, Aurélien J Mazurie, Anastasiya Nestsiarovich, Douglas J Perkins, Quentin L Schroeter, Alicia N Smith, Mauricio Tohen, Emma Volesky, Yiliang Zhu & Christophe G Lambert. (2019) Preferences of Information Dissemination on Treatment for Bipolar Disorder: Patient-Centered Focus Group Study. JMIR Mental Health 6:6, pages e12848.
Crossref
Tammas Kelly. (2019) Lithium and the Woozle effect. Bipolar Disorders 21:4, pages 302-308.
Crossref
Jong-Hyun Jeong, Won-Myong Bahk, Young Sup Woo, Jung Goo Lee, Moon-Doo Kim, InKi Sohn, Se-Hoon Shim, Duk-In Jon, Jeong Seok Seo, Won Kim, Hoo-Rim Song, Kyung Joon Min & Bo-Hyun Yoon. (2019) Korean Medication Algorithm for Bipolar Disorder 2018: Comparisons with Other Treatment Guidelines. Clinical Psychopharmacology and Neuroscience 17:2, pages 155-169.
Crossref
YC Janardhan Reddy, Venugopal Jhanwar, Rajesh Nagpal, MS Reddy, Nilesh Shah, Sanman Ghorpade & Sujay Kulkarni. (2019) Prescribing practices of Indian psychiatrists in the treatment of bipolar disorder. Australian & New Zealand Journal of Psychiatry 53:5, pages 458-469.
Crossref
Radmila Kučíková & Katarína Hánělová. (2019) Vortioxetin in treatment of depressive epizode within bipolar affective disorder. Psychiatrie pro praxi 20:1, pages 27-28.
Crossref
Gabriela Tavella & Philip Boyce. 2018. Bipolar II Disorder. Bipolar II Disorder 151 162 .
Gabriela Tavella & Gordon Parker. 2018. Bipolar II Disorder. Bipolar II Disorder 108 112 .
. 2019. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen 1 119 .
Andrea Botturi, Lucio Oldani & Francesca Bottinelli. 2019. Clinical Cases in Psychiatry: Integrating Translational Neuroscience Approaches. Clinical Cases in Psychiatry: Integrating Translational Neuroscience Approaches 189 208 .
Wael Mahmoud Aboulthana & Noha El-Sayed Ibrahim. (2018) A renoprotective role of chitosan against lithium-induced renal toxicity in rats. Bulletin of the National Research Centre 42:1.
Crossref
Pernille Kempel Ellegaard, Rasmus Wentzer Licht, Henrik Enghusen Poulsen, René Ernst Nielsen, Michael Berk, Olivia May Dean, Mohammadreza Mohebbi & Connie Thuroee Nielsen. (2018) Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol). International Journal of Bipolar Disorders 6:1.
Crossref
M Nederlof, RW Kupka, AM Braam, ACG Egberts & ER Heerdink. (2018) Evaluation of clarity of presentation and applicability of monitoring instructions for patients using lithium in clinical practice guidelines for treatment of bipolar disorder. Bipolar Disorders 20:8, pages 708-720.
Crossref
Cho-Yin Huang, Shu-Yu Yang, Ramin Mojtabai, Shu-Ku Lin, Yan-Ling He, Mian-Yoon Chong, Gabor Ungvari, Chay-Hoon Tan, Yu-Tao Xiang, Norman Sartorius, Naotaka Shinfuku & Lian-Yu Chen. (2018) Trends of Polypharmacy and Prescription Patterns of Antidepressants in Asia. Journal of Clinical Psychopharmacology 38:6, pages 598-603.
Crossref
Ayodele L. Fela-Thomas, Osasu S. Olotu & Oluyomi Esan. (2018) Risk of manic switch with antidepressants use in patients with bipolar disorder in a Nigerian neuropsychiatric hospital. South African Journal of Psychiatry 24.
Crossref
Julia Dehning, Heinz Grunze, Michaela Walpoth-Niederwanger, Georg Kemmler & Armand Hausmann. (2018) The use of (newer) antipsychotics in bipolar inpatients over a 17-year observation period. International Clinical Psychopharmacology 33:6, pages 297-303.
Crossref
Andrea Marotta, Roberto Delle Chiaie, Laura Bernabei, Rosangela Grasso, Massimo Biondi & Maria Casagrande. (2018) Investigating gaze processing in euthymic bipolar disorder: Impaired ability to infer mental state and intention, but preservation of social attentional orienting. Quarterly Journal of Experimental Psychology 71:10, pages 2041-2051.
Crossref
Farid Talih, Nour Y. Gebara, Farah S. Andary, Stefania Mondello, Firas Kobeissy & Raffaele Ferri. (2018) Delayed sleep phase syndrome and bipolar disorder: Pathogenesis and available common biomarkers. Sleep Medicine Reviews 41, pages 133-140.
Crossref
Mitsukuni Murasaki, Tsukasa Koyama, Shigenobu Kanba, Masahiro Takeuchi, Yuriko Shimizu, Eri Arita, Kentaro Kuroishi, Masahiro Takeuchi & Shinya Kamei. (2018) Multi-center, randomized, double-blind, placebo-controlled study of quetiapine extended-release formulation in Japanese patients with bipolar depression. Psychopharmacology 235:10, pages 2859-2869.
Crossref
N. Verdolini, D. Hidalgo-Mazzei, A. Murru, I. Pacchiarotti, L. Samalin, A. H. Young, E. Vieta & A. F. Carvalho. (2018) Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines. Acta Psychiatrica Scandinavica 138:3, pages 196-222.
Crossref
Michele Fornaro, Annalisa Anastasia, Francesco Monaco, Stefano Novello, Andrea Fusco, Felice Iasevoli, Domenico De Berardis, Nicola Veronese, Marco Solmi & Andrea de Bartolomeis. (2018) Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants. Journal of Affective Disorders 234, pages 131-138.
Crossref
Maxine X Patel, Faisil N Sethi, Thomas RE Barnes, Roland Dix, Luiz Dratcu, Bernard Fox, Marina Garriga, Julie C Haste, Kai G Kahl, Anne Lingford-Hughes, Hamish McAllister-Williams, Aileen O’Brien, Caroline Parker, Brodie Paterson, Carol Paton, Sotiris Posporelis, David M Taylor, Eduard Vieta, Birgit Völlm, Charlotte Wilson-Jones & Laura Woods. (2018) Joint BAP NAPICU evidence-based consensus guidelines for the clinical management of acute disturbance: De-escalation and rapid tranquillisation. Journal of Psychopharmacology 32:6, pages 601-640.
Crossref
Horacio A. Capote, Michelle Rainka, Erica S. Westphal, Jonathan Beecher & Francis M. Gengo. (2018) Ropinirole in Bipolar Disorder: Rate of Manic Switching and Change in Disease Severity. Perspectives in Psychiatric Care 54:2, pages 100-106.
Crossref
Trude Seselie Jahr Iversen, Nils Eiel Steen, Ingrid Dieset, Sigrun Hope, Ragni Mørch, Erlend Strand Gardsjord, Kjetil Nordbø Jørgensen, Ingrid Melle, Ole A. Andreassen, Espen Molden & Erik G. Jönsson. (2018) Side effect burden of antipsychotic drugs in real life – Impact of gender and polypharmacy. Progress in Neuro-Psychopharmacology and Biological Psychiatry 82, pages 263-271.
Crossref
Martin Alda & Mirko Manchia. (2018) Personalized management of bipolar disorder. Neuroscience Letters 669, pages 3-9.
Crossref
Gordon B. Parker & Gabriela Tavella. (2018) Design limitations to bipolar II treatment efficacy studies: A challenge and a revisionist strategy. Journal of Affective Disorders 229, pages 334-341.
Crossref
Rebecca K. Graham, Gabriela Tavella & Gordon B. Parker. (2018) Is there consensus across international evidence-based guidelines for the psychotropic drug management of bipolar disorder during the perinatal period?. Journal of Affective Disorders 228, pages 216-221.
Crossref
Yahav Shvartzman, Amir Krivoy, Avi Valevski, Shay Gur, Abraham Weizman & Eldar Hochman. (2018) Adjunctive antidepressants in bipolar depression: A cohort study of six- and twelve-months rehospitalization rates. European Neuropsychopharmacology 28:3, pages 353-360.
Crossref
M Kristensen, A A Nierenberg & S D Østergaard. (2017) Face and predictive validity of the ClockΔ19 mouse as an animal model for bipolar disorder: a systematic review. Molecular Psychiatry 23:1, pages 70-80.
Crossref
Fiona Chautant & Laure Rouch. 2018. Pharmacie Clinique et Thérapeutique. Pharmacie Clinique et Thérapeutique 693 714.e1 .
Salih Selek & Jair C. Soares. 2018. Understanding Depression. Understanding Depression 269 275 .
Ayal Schaffer, Lauren M. Weinstock, Mark Sinyor, Catherine Reis, Benjamin I. Goldstein, Lakshmi N. Yatham & Anthony J. Levitt. (2017) Self-poisoning suicide deaths in people with bipolar disorder: characterizing a subgroup and identifying treatment patterns. International Journal of Bipolar Disorders 5:1.
Crossref
Diego F Tavares, Martin L Myczkowski, Rodrigo L Alberto, Leandro Valiengo, Rosa M Rios, Pedro Gordon, Bernardo de Sampaio-Junior, Izio Klein, Carlos G Mansur, Marco Antonio Marcolin, Beny Lafer, Ricardo A Moreno, Wagner Gattaz, Zafiris J Daskalakis & André R Brunoni. (2017) Treatment of Bipolar Depression with Deep TMS: Results from a Double-Blind, Randomized, Parallel Group, Sham-Controlled Clinical Trial. Neuropsychopharmacology 42:13, pages 2593-2601.
Crossref
C. Rovera, C. M. Esposito, V. Ciappolino, D. Cattaneo, S. Baldelli, E. Clementi, A. C. Altamura & M. Buoli. (2017) Quetiapine-Induced Hypomania and its Association with Quetiapine/Norquetiapine Plasma Concentrations: A Case Series of Bipolar Type 2 Patients. Drug Safety - Case Reports 4:1.
Crossref
William V. Bobo. (2017) The Diagnosis and Management of Bipolar I and II Disorders: Clinical Practice Update. Mayo Clinic Proceedings 92:10, pages 1532-1551.
Crossref
Louise B. Bjørklund, Henriette T. Horsdal, Ole Mors, Christiane Gasse & Søren D. Østergaard. (2017) Psychopharmacological treatment of psychotic mania and psychotic bipolar depression compared to non-psychotic mania and non-psychotic bipolar depression. Bipolar Disorders 19:6, pages 505-512.
Crossref
Roland Ricken, Sven Ulrich, Peter Schlattmann & Mazda Adli. (2017) Tranylcypromine in mind (Part II): Review of clinical pharmacology and meta-analysis of controlled studies in depression. European Neuropsychopharmacology 27:8, pages 714-731.
Crossref
Lesley J. Robertson, Jacqui K. Miot & Bernard Janse van Rensburg. (2017) A retrospective record review and assessment of cost of quetiapine use in a community psychiatric setting in the Sedibeng district of Gauteng. South African Journal of Psychiatry 23.
Crossref
G. B. Parker, R. K. Graham & G. Tavella. (2017) Is there consensus across international evidence-based guidelines for the management of bipolar disorder?. Acta Psychiatrica Scandinavica 135:6, pages 515-526.
Crossref
Julia Dehning, Heinz Grunze & Armand Hausmann. (2017) Bupropion Maintenance Treatment in Refractory Bipolar Depression: A Case Report. Clinical Practice & Epidemiology in Mental Health 13:1, pages 43-48.
Crossref
Tom MunyerSarah Norman. 2017. PharmacotherapyFirst: A Multimedia Learning Resource. PharmacotherapyFirst: A Multimedia Learning Resource.
Ali Mezni, Abdelhafidh Khazri, Olfa Khazri, Ferid Limam, Pascal Cosette & Ezzeddine Aouani. (2016) Neuroprotective Activity of Grape Seed and Skin Extract Against Lithium Exposure Using Proteomic Research. Molecular Neurobiology 54:4, pages 2720-2730.
Crossref
Stephen M. Stahl, Debbi A. Morrissette, Gianni Faedda, Maurizio Fava, Joseph F. Goldberg, Paul E. Keck, Yena Lee, Gin Malhi, Ciro Marangoni, Susan L. McElroy, Michael Ostacher, Joshua D. Rosenblat, Eva Solé, Trisha Suppes, Minoru Takeshima, Michael E. Thase, Eduard Vieta, Allan Young, Mark Zimmerman & Roger S. McIntyre. (2017) Guidelines for the recognition and management of mixed depression. CNS Spectrums 22:2, pages 203-219.
Crossref
Sergio De Filippis, Ilaria Cuomo, Georgios D. Kotzalidis, Daniela Pucci, Pietro Zingaretti, Raffaella Porrari, Camilla Fini, Paola Motta, Matteo Caloro & Paolo Girardi. (2016) Does the efficacy of asenapine in bipolar disorder increase in the presence of comorbidity with a substance use disorder? A naturalistic study. Therapeutic Advances in Psychopharmacology 7:2, pages 67-77.
Crossref
Paulo R. Nunes Neto, Cristiano A. Köhler, Michael Berk & André F. Carvalho. 2017. Mental Disorders in Primary Care. Mental Disorders in Primary Care 151 170 .
Maj Vinberg, Rie Lambaek Mikkelsen, Thomas Kirkegaard, Ellen Margrethe Christensen & Lars Vedel Kessing. (2017) Differences in clinical presentation between bipolar I and II disorders in the early stages of bipolar disorder: A naturalistic study. Journal of Affective Disorders 208, pages 521-527.
Crossref
. 2017. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen 1 111 .
Giulio Perugi, Giulia Vannucchi, Fulvio Bedani & Ettore Favaretto. (2017) Use of Stimulants in Bipolar Disorder. Current Psychiatry Reports 19:1.
Crossref
Michael Bauer, Emanuel Severus & Gerd Laux. 2017. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie 1819 1854 .
Pierre Alexis Geoffroy & Bruno Etain. 2017. The Science and Practice of Lithium Therapy. The Science and Practice of Lithium Therapy 111 124 .
Chantal Henry, Aroldo A. Dargél & Jan Scott. 2017. The Science and Practice of Lithium Therapy. The Science and Practice of Lithium Therapy 211 222 .
Annemiek Dols, Lars Vedel Kessing, Sergio A. Strejilevich, Soham Rej, Shang-Ying Tsai, Ariel G. Gildengers, Osvaldo P. Almeida, Kenneth I. Shulman & Martha Sajatovic. (2016) Do current national and international guidelines have specific recommendations for older adults with bipolar disorder? A brief report. International Journal of Geriatric Psychiatry 31:12, pages 1295-1300.
Crossref
Konstantinos N. Fountoulakis, Lakshmi Yatham, Heinz Grunze, Eduard Vieta, Allan Young, Pierre Blier, Siegfried Kasper & Hans Jurgen Moeller. (2016) The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm. International Journal of Neuropsychopharmacology, pages pyw100.
Crossref
Pierre Alexis Geoffroy, Ludovic Samalin, Pierre-Michel Llorca, Emmanuel Curis & Frank Bellivier. (2016) Influence of lithium on sleep and chronotypes in remitted patients with bipolar disorder. Journal of Affective Disorders 204, pages 32-39.
Crossref
Ping-Tao Tseng, Yen-Wen Chen, Kun-Yu Tu, Weilun Chung, Hung-Yu Wang, Ching-Kuan Wu & Pao-Yen Lin. (2016) Light therapy in the treatment of patients with bipolar depression: A meta-analytic study. European Neuropsychopharmacology 26:6, pages 1037-1047.
Crossref
Terence A. Ketter, Kaushik Sarma, Robert Silva, Hans Kroger, Josephine Cucchiaro & Antony Loebel. (2016) LURASIDONE IN THE LONG‐TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24‐WEEK OPEN‐LABEL EXTENSION STUDY. Depression and Anxiety 33:5, pages 424-434.
Crossref
Louise Bjørklund, Henriette Thisted Horsdal, Ole Mors, Søren Dinesen Østergaard & Christiane Gasse. (2015) Trends in the psychopharmacological treatment of bipolar disorder: a nationwide register-based study. Acta Neuropsychiatrica 28:2, pages 75-84.
Crossref
Nilesh Shah, M.S. Reddy, Sandeep Vohra, Uday Chaudhuri & Senthilnathan Mohanasundaram. (2016) Safety and effectiveness of divalproex sodium extended release containing regimen in Indian patients with bipolar I disorder in continuation phase: Results of EASED registry. Asian Journal of Psychiatry 20, pages 32-38.
Crossref
Lars Vedel Kessing, Eleni Vradi & Per Kragh Andersen. (2016) Nationwide and population-based prescription patterns in bipolar disorder. Bipolar Disorders 18:2, pages 174-182.
Crossref
Lindsay M Avery & Shannon J Drayton. (2016) Bipolar depression. The International Journal of Psychiatry in Medicine 51:2, pages 145-159.
Crossref
Terence A. Ketter, Shefali Miller, Bernardo Dell’Osso & Po W. Wang. (2016) Treatment of bipolar disorder: Review of evidence regarding quetiapine and lithium. Journal of Affective Disorders 191, pages 256-273.
Crossref
N. N. Ivanets, M. A. Kinkulkina, T. I. Avdeeva, Yu. G. Tikhonova & A. V. Luk’ianova. (2016) An increase in the efficacy of psychopharmacotherapy of late-onset depressions: combination and substitution of antidepressants. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 116:5, pages 43.
Crossref
Alencar Kolinski Machado, Ana Cristina Andreazza, Tatiane Morgana da Silva, Aline Augusti Boligon, Vanusa do Nascimento, Gustavo Scola, Angela Duong, Francine Carla Cadoná, Euler Esteves Ribeiro & Ivana Beatrice Mânica da Cruz. (2016) Neuroprotective Effects of Açaí ( Euterpe oleracea Mart.) against Rotenone In Vitro Exposure . Oxidative Medicine and Cellular Longevity 2016, pages 1-14.
Crossref
Samuel Bulteau, Nelly Doligez, Caroline Victorri-Vigneau, Edouard Laforgue, Marie Guitteny, Anne Sauvaget & Jean-Marie Vanelle. (2016) Les antidépresseurs ont-ils encore un intérêt dans la dépression bipolaire ?. Annales Médico-psychologiques, revue psychiatrique 174:1, pages 70-76.
Crossref
C.L. Bowden & M. Melissa. 2016. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
John L. Beyer & K. Ranga R. Krishnan. 2016. Bipolar Depression: Molecular Neurobiology, Clinical Diagnosis, and Pharmacotherapy. Bipolar Depression: Molecular Neurobiology, Clinical Diagnosis, and Pharmacotherapy 289 313 .
Marco Mula. 2016. Neuropsychiatric Symptoms of Epilepsy. Neuropsychiatric Symptoms of Epilepsy 43 51 .
Fan Wu, Eric B Laber, Ilya A Lipkovich & Emanuel Severus. (2015) Who will benefit from antidepressants in the acute treatment of bipolar depression? A reanalysis of the STEP-BD study by Sachs et al. 2007, using Q-learning. International Journal of Bipolar Disorders 3:1.
Crossref
Trine Naalsund Andreassen, Berit Margrethe Hasle Falch & Olav Spigset. (2015) A UPLC–MSMS method for the analysis of olanzapine in serum—with particular emphasis on drug stability testing. Journal of Chromatography B 1006, pages 112-120.
Crossref
Axel Nordenskj?ld. (2015) ECT is superior to pharmacotherapy for the short-term treatment of medication-resistant inpatients with bipolar depression. Evidence Based Mental Health 18:4, pages 118-118.
Crossref
Ayal Schaffer, Erkki T Isometsä, Leonardo Tondo, Doris H Moreno, Mark Sinyor, Lars Vedel Kessing, Gustavo Turecki, Abraham Weizman, Jean-Michel Azorin, Kyooseob Ha, Catherine Reis, Frederick Cassidy, Tina Goldstein, Zoltán Rihmer, Annette Beautrais, Yuan-Hwa Chou, Nancy Diazgranados, Anthony J Levitt, Carlos A ZarateJrJr & Lakshmi Yatham. (2015) Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder. Australian & New Zealand Journal of Psychiatry 49:9, pages 785-802.
Crossref
Andrea Marotta, Roberto Delle Chiaie, Alfredo Spagna, Laura Bernabei, Martina Sciarretta, Javier Roca, Massimo Biondi & Maria Casagrande. (2015) Impaired conflict resolution and vigilance in euthymic bipolar disorder. Psychiatry Research 229:1-2, pages 490-496.
Crossref
Mitsuhiro Tada, Hiroyuki Uchida, Jin Mizushima, Takefumi Suzuki, Masaru Mimura & Shintaro Nio. (2015) Antidepressant dose and treatment response in bipolar depression: Reanalysis of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) data. Journal of Psychiatric Research 68, pages 151-156.
Crossref
Yuan Hwa Chou, Po-Chung Chu, Szu-Wei Wu, Jen-Chin Lee, Yi-Hsuan Lee, I-Wen Sun, Chen-Lin Chang, Chien-Liang Huang, I-Chao Liu, Chia-Fen Tsai & Yung-Chieh Yen. (2015) A Systemic Review and Experts’ Consensus for Long-acting Injectable Antipsychotics in Bipolar Disorder. Clinical Psychopharmacology and Neuroscience 13:2, pages 121-128.
Crossref
Jennifer Nicholas, Mark Erik Larsen, Judith Proudfoot & Helen Christensen. (2015) Mobile Apps for Bipolar Disorder: A Systematic Review of Features and Content Quality. Journal of Medical Internet Research 17:8, pages e198.
Crossref
Zuowei Wang, Jun Chen, Chen Zhang, Keming Gao, Wu Hong, Mengjuan Xing, Zhiguo Wu, Chengmei Yuan, Jia Huang, Daihui Peng, Yong Wang, Weihong Lu, Zhenghui Yi, Xin Yu, Jingping Zhao & Yiru Fang. (2015) Guidelines concordance of maintenance treatment in euthymic patients with bipolar disorder: Data from the national bipolar mania pathway survey (BIPAS) in mainland China. Journal of Affective Disorders 182, pages 101-105.
Crossref
Jonathan D. Brown, Allison Barrett, Kerianne Hourihan, Emily Caffery & Henry T. Ireys. (2015) State Variation in the Delivery of Comprehensive Services for Medicaid Beneficiaries with Schizophrenia and Bipolar Disorder. Community Mental Health Journal 51:5, pages 523-534.
Crossref
Benny Liberg, Carl Johan Ekman, Carl Sellgren, Anette G. Johansson & Mikael Landén. (2014) Subcortical morphometry and psychomotor function in euthymic bipolar disorder with a history of psychosis. Brain Imaging and Behavior 9:2, pages 333-341.
Crossref
Atefeh Zeinoddini, Maryam Sorayani, Elmira Hassanzadeh, Mohammad Arbabi, Mehdi Farokhnia, Samrand Salimi, Ali Ghaleiha & Shahin Akhondzadeh. (2015) PIOGLITAZONE ADJUNCTIVE THERAPY FOR DEPRESSIVE EPISODE OF BIPOLAR DISORDER: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL. Depression and Anxiety 32:3, pages 167-173.
Crossref
. 2015. Therapie Psychischer Erkrankungen. Therapie Psychischer Erkrankungen e1 e96 .
Rasmus Wentzer Licht. 2015. Clinical Trial Design Challenges in Mood Disorders. Clinical Trial Design Challenges in Mood Disorders 137 165 .
Michael Soyka & Heinz Grunze. 2015. Co-occurring Addictive and Psychiatric Disorders. Co-occurring Addictive and Psychiatric Disorders 279 306 .
Michael Bauer, Emanuel Severus & Gerd Laux. 2016. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie 1 36 .
Kostas N. FountoulakisKostas N. Fountoulakis. 2015. Bipolar Disorder. Bipolar Disorder 643 658 .
Pierre-Michel Llorca & Ludovic Samalin. 2015. Neuropsychiatric Symptoms of Inflammatory Demyelinating Diseases. Neuropsychiatric Symptoms of Inflammatory Demyelinating Diseases 95 103 .
Alexandra Kutzelnigg, Martin Kopeinig, Chih-Ken Chen, Ágnes Fábián, María Gloria Pujol-Luna, Young-chul Shin, Tamás Treuer, Yulia D'yachkova, Claudia Deix, Siegfried Kasper & Dagmar Doby. (2014) Compliance as a stable function in the treatment course of bipolar disorder in patients stabilized on olanzapine: results from a 24-month observational study. International Journal of Bipolar Disorders 2:1.
Crossref
Elias Koutsoukos & Elias Angelopoulos. (2014) Mood regulation in bipolar disorders viewed through the pendulum dynamics concept. International Journal of Bipolar Disorders 2:1.
Crossref
Pierre Alexis Geoffroy, Bruno Etain, Sarah Sportiche & Frank Bellivier. (2014) Circadian biomarkers in patients with bipolar disorder: promising putative predictors of lithium response. International Journal of Bipolar Disorders 2:1.
Crossref
Zuowei Wang, Keming Gao, Wu Hong, Mengjuan Xing, Zhiguo Wu, Jun Chen, Chen Zhang, Chengmei Yuan, Jia Huang, Daihui Peng, Yong Wang, Weihong Lu, Zhenghui Yi, Xin Yu, Jingping Zhao & Yiru Fang. (2014) Pharmacotherapy for acute mania and disconcordance with treatment guidelines: bipolar mania pathway survey (BIPAS) in mainland China. BMC Psychiatry 14:1.
Crossref
Daniel Schuepbach & Erich Seifritz. (2014) Pharmakotherapie der bipolaren Störungen und der Manie. Zeitschrift für Psychiatrie, Psychologie und Psychotherapie 62:4, pages 243-254.
Crossref
S. K?hler, M. Bauer & T. Bschor. (2013) Pharmakologische Behandlung der bipolaren DepressionPharmaceutical treatment of bipolar depression. Der Nervenarzt 85:9, pages 1075-1083.
Crossref
H.-J. Möller, F. Seemüller, R. Schennach-Wolff, S. Stübner, E. Rüther & R. Grohmann. (2013) History, background, concepts and current use of comedication and polypharmacy in psychiatry. The International Journal of Neuropsychopharmacology 17:07, pages 983-996.
Crossref
Franck Bellivier. (2014) Variabilité de la réponse au lithium. Annales Médico-psychologiques, revue psychiatrique 172:3, pages 199-201.
Crossref
Ludovic Samalin & Pierre-Michel Llorca. (2014) Avis critique sur la place du lithium dans les recommandations professionnelles sur la prise en charge du trouble bipolaire. Annales Médico-psychologiques, revue psychiatrique 172:3, pages 177-181.
Crossref
Zuowei Wang, Keming Gao, Wu Hong, Mengjuan Xing, Zhiguo Wu, Jun Chen, Chen Zhang, Chengmei Yuan, Jia Huang, Daihui Peng, Yong Wang, Weihong Lu, Zhenghui Yi, Xin Yu, Jingping Zhao & Yiru Fang. (2014) Guidelines Disconcordance in Acute Bipolar Depression: Data from the National Bipolar Mania Pathway Survey (BIPAS) in Mainland China. PLoS ONE 9:4, pages e96096.
Crossref
Natalia Bartolommei, Francesco Casamassima, Laura Pensabene, Federica Luchini, Antonella Benvenuti, Antonello Di Paolo, Luca Cosentino, Mauro Mauri & Lorenzo Lattanzi. (2014) Ziprasidone as Adjunctive Therapy in Severe Bipolar Patients Treated with Clozapine. ISRN Psychiatry 2014, pages 1-7.
Crossref
S?ren Dinesen ?stergaard, Sune Straszek, Georgios Petrides, S?ren Skadhede, Signe Olrik Wallenstein Jensen, Povl Munk-J?rgensen & Jimmi Nielsen. (2014) Risk factors for conversion from unipolar psychotic depression to bipolar disorder. Bipolar Disorders 16:2, pages 180-189.
Crossref
Benny Liberg, Carl Johan Ekman, Carl Sellgren, Anette Johansson & Mikael Landén. (2014) Vertex-based morphometry in euthymic bipolar disorder implicates striatal regions involved in psychomotor function. Psychiatry Research: Neuroimaging 221:3, pages 173-178.
Crossref
Michael Bauer, Tasha Glenn, Maximilian Pilhatsch, Andrea Pfennig & Peter C Whybrow. (2013) Gender differences in thyroid system function: relevance to bipolar disorder and its treatment. Bipolar Disorders 16:1, pages 58-71.
Crossref
. 2014. Therapie Psychischer Erkrankungen. Therapie Psychischer Erkrankungen 1 91 .
Bruno Millet, Jean-Marie Vanelle & Joseph Benyaya. 2014. Prescrire les psychotropes. Prescrire les psychotropes 101 118 .
Allan H Young, Joseph R Calabrese, Urban Gustafsson, Michael Berk, Susan L McElroy, Michael E Thase, Trisha Suppes & Willie Earley. (2013) Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies. International Journal of Bipolar Disorders 1:1.
Crossref
Sabrina Paterniti & Jean-Claude Bisserbe. (2013) Pharmacotherapy for bipolar disorder and concordance with treatment guidelines: survey of a general population sample referred to a tertiary care service. BMC Psychiatry 13:1.
Crossref
Susanne Kraemer, Anette Minarzyk, Steffen Eppendorfer, Carsten Henneges, Hans-Peter Hundemer, Stefan Wilhelm & Heinz Grunze. (2013) Comparably high retention and low relapse rates in different subpopulations of bipolar patients in a German non-interventional study. BMC Psychiatry 13:1.
Crossref
Tomasz Gos, Johann Steiner, Dieter Krell, Hendrik Bielau, Christian Mawrin, Maciej Krzyżanowski, Ralf Brisch, Dorota Pieśniak, Hans-Gert Bernstein, Zbigniew Jankowski, Katharina Braun & Bernhard Bogerts. (2013) Ribosomal DNA transcription in the anterior cingulate cortex is decreased in unipolar but not bipolar I depression. Psychiatry Research 210:1, pages 338-345.
Crossref
Leslie Citrome. (2013) A Review of the Pharmacology, Efficacy and Tolerability of Recently Approved and Upcoming Oral Antipsychotics: An Evidence-Based Medicine Approach. CNS Drugs 27:11, pages 879-911.
Crossref
M. Köster, R. Grohmann, R. R. Engel, M. A. Nitsche, E. Rüther & D. Degner. (2013) Seizures during antidepressant treatment in psychiatric inpatients—results from the transnational pharmacovigilance project “Arzneimittelsicherheit in der Psychiatrie” (AMSP) 1993–2008. Psychopharmacology 230:2, pages 191-201.
Crossref
Maria Fe Bravo, Guillermo Lahera, Lluis Lalucat & Alberto Fernández-Liria. (2013) Guía de práctica clínica sobre el trastorno bipolar: tratamiento farmacológico y psicosocial. Medicina Clínica 141:7, pages 305.e1-305.e10.
Crossref
Ya-Mei Bai, Ching-Jui Chang, Shang-Ying Tsai, Yi-Chyan Chen, Mei-Chun Hsiao, Cheng-Ta Li, Peichi Tu, Shang-Wen Chang, Winston W. Shen & Tung-Ping Su. (2013) Taiwan consensus of pharmacological treatment for bipolar disorder. Journal of the Chinese Medical Association 76:10, pages 547-556.
Crossref
Eduard Vieta, Jens M. Langosch, Maria Luisa Figueira, Daniel Souery, Elena Blasco-Colmenares, Esteban Medina, Miriam Moreno-Manzanaro, Miguel Angel Gonzalez & Frank Bellivier. (2013) Clinical management and burden of bipolar disorder: results from a multinational longitudinal study (WAVE-bd). International Journal of Neuropsychopharmacology 16:8, pages 1719-1732.
Crossref
Philip B MitchellBernardo Dell’Osso. 2013. Clinical Management of Bipolar Disorder. Clinical Management of Bipolar Disorder 46 59 .
Gustavo H. Vázquez, Leonardo Tondo, Juan Undurraga & Ross J. Baldessarini. (2013) Overview of antidepressant treatment of bipolar depression. International Journal of Neuropsychopharmacology 16:7, pages 1673-1685.
Crossref

Displaying 200 of 289 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.